This book investigates the challenges and strategies in discovering new drugs for neglected diseases. It examines the scientific, economic, and ethical hurdles that impede the development of treatments for conditions that disproportionately affect impoverished populations. The work draws upon expertise in medicinal chemistry, pharmacology, and public health to outline potential pathways for innovation and improved access to essential medicines.

The book is likely to be regarded as a comprehensive overview of the complex issues surrounding drug discovery for neglected diseases. Its focus on scientific, economic, and ethical dimensions suggests it aims to inform researchers, policymakers, and public health professionals. The detailed scope indicates a text intended for those with a background in the field, offering insights into current challenges and future directions.